Total Funding
87
79
Total FundingSeries B raised
Growth Score
-7 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15817
VahatiCor develops the A-FLUX Reducer System for coronary microvascular dysfunction relief.
- Harry Rowland: Chief Executive OfficerPast Role: Edwards Lifesciences, SVP of IHFM Innovation
- Marwan Berrada-Sounni: Founder and Chairman
About the Company
VahatiCor specializes in medical equipment manufacturing, focusing on solutions for coronary microvascular dysfunction. The company is known for its A-FLUX Reducer System, which addresses the complexities of ischemic heart disease and provides relief for patients experiencing angina and chest pain. VahatiCor aims to improve coronary
microcirculatory function with its next-generation medical technologies.
